Hemagen Diagnostics (HMGN) Stock Price, News & Analysis

Company Overview

Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.

Key Stats

• Today's Range: $0.0150 to $0.0150
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0150
• Volume: N/A
• Average Volume: 7,143 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HMGN Stock Analysis - Frequently Asked Questions

How have HMGN shares performed this year?

Hemagen Diagnostics' stock was trading at $0.0001 on January 1st, 2025. Since then, HMGN shares have increased by 14,900.0% and is now trading at $0.0150.

How do I buy shares of Hemagen Diagnostics?

Shares of HMGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Hemagen Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemagen Diagnostics investors own include Tesla (TSLA) and Shopify (SHOP).

Company Calendar

• Today: 8/22/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:HMGN
• CIK: N/A
• Web: www.hemagen.com
• Phone: (443) 367-5500
• Fax: 443-367-5527
• Employees: 15
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A